Diabetes patients who have a lower propensity to reach out

Mistrust can exact a high toll. Being overly cautious or dismissive in relating to people, scientists are learning, may shorten the lives of people with diabetes. Diabetes patients who have a lower propensity to reach out to others have a higher mortality rate than those who feel comfortable seeking support. These are the findings of a five-year study reported by Dr. Paul Ciechanowski, associate professor of psychiatry and behavioral sciences at the University of Washington (UW) and an affiliate investigator at Group Health Research Institute in Seattle……..

Caution in reducing blood pressure in patients with diabetes, coronary disease

For patients with diabetes and heart disease, less isn’t always more at least when it comes to blood pressure. New data show an increased risk of heart attack, stroke or death for patients having blood pressure deemed too high or too low, as per Rhonda Cooper-DeHoff, Pharm.D., an associate professor of pharmacy and medicine at UF. She reported her findings today (Sunday, March 14) at the American College of Cardiology’s 59th annual scientific session in Atlanta……..

Rapid-acting insulin analogues

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term therapy with rapid-acting insulin analogues than with short-acting human insulin. Certainly, there is no proof of additional benefit from the available results from clinical trials of maximum one year duration. This applies both in the comparison with human insulin and in the comparison between analogues only. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 November 2009……..

Diabetes' link to eating disorders

Diabetics, under the gun to better manage their disease by controlling their food intake and weight, may find themselves in the sticky wicket of needing therapy that makes them hungry, scientists said. Attempts to maintain healthy blood sugar levels and prevent weight gain may suggest an eating disorder when the disease and its therapy are to blame, said Dr. Deborah Young-Hyman, pediatric psychology expert at the Medical College of Georgia’s Georgia Prevention Institute……..

Diabetes drug increases risk for bone fractures

A Henry Ford Hospital study finds women with type 2 diabetes who take a usually prescribed class of medications to treat insulin resistance appears to be at a higher risk for developing bone fractures. After taking a thiazolidinedione (TZD) for one year, women are 50 percent more likely to have a bone fracture than patients not taking TZDs, as per study results. And those at the greatest risk for fractures from TZD use are women older than 65……..

Sleep apnea and diabetes

Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, as per a research studyconducted by scientists at the University of Chicago. The study „demonstrates for the first time that there is a clear, graded, inverse relationship between OSA severity and glucose control in patients with type 2 diabetes,“ wrote main author, Renee S. Aronsohn, M.D., instructor of medicine at the University of Chicago……..

Aim at cure: type 1 diabetes

A hormone responsible for the body’s stress response is also associated with the growth of insulin-producing cells in the pancreas, as per JDRF- funded scientists at the Salk Institute for Biological Studies in California. The findings are the latest advances to underscore the potential for regeneration as a key component of a possible cure for type 1 diabetes……..

Pharmacists Improve Care of Diabetics While Cutting Costs

The role of pharmacists hasn’t received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce therapy costs and improve outcomes. A study on diabetic patients by the University at Buffalo School of Pharmacy and Pharmaceutical Sciences identified cost savings with improvements in a key indicator of glucose control in diabetes patients, the hemoglobin A1C measurement. The A1C provides a three-month average of the amount of excess glucose in the blood. Higher A1Cs indicate that a patient is at higher risk for developing long-term complications linked to diabetes, such as kidney disease or vision problems……..